Literature DB >> 21643783

Renal issues in HIV infection.

Robert C Kalayjian1.   

Abstract

Kidney disease remains a prominent complication of HIV disease, despite beneficial effects of antiretroviral therapy on the natural history of HIV-associated nephropathy, and on kidney function in general populations of HIV infected patients. Persons of African descent continue to bear a disproportionate burden of severe kidney disease, as is true for the general population. Recently identified genetic variants in the apolipoprotein L1 gene may contribute to this burden. As is also true for the general population, markers of kidney disease, including microalbuminuria, are sensitive predictors of cardiovascular disease and mortality among persons living with HIV. The emerging experience with kidney transplantation also suggests this to be a viable option in selected patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643783     DOI: 10.1007/s11904-011-0080-x

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  59 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice.

Authors:  Björn Hartleben; Markus Gödel; Catherine Meyer-Schwesinger; Shuya Liu; Theresa Ulrich; Sven Köbler; Thorsten Wiech; Florian Grahammer; Sebastian J Arnold; Maja T Lindenmeyer; Clemens D Cohen; Hermann Pavenstädt; Dontscho Kerjaschki; Noboru Mizushima; Andrey S Shaw; Gerd Walz; Tobias B Huber
Journal:  J Clin Invest       Date:  2010-04       Impact factor: 14.808

3.  Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.

Authors:  Andy Choi; Rebecca Scherzer; Peter Bacchetti; Phyllis C Tien; Michael S Saag; Cynthia L Gibert; Lynda A Szczech; Carl Grunfeld; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2010-08-14       Impact factor: 8.860

4.  Serious fatal and nonfatal non-AIDS-defining illnesses in Europe.

Authors:  Amanda Mocroft; Peter Reiss; Jacek Gasiorowski; Bruno Ledergerber; Justyna Kowalska; Antonio Chiesi; Jose Gatell; Aza Rakhmanova; Margaret Johnson; Ole Kirk; Jens Lundgren
Journal:  J Acquir Immune Defic Syndr       Date:  2010-10       Impact factor: 3.731

5.  Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects.

Authors:  Samir K Gupta; Lauren Komarow; Roy M Gulick; Richard B Pollard; Gregory K Robbins; Nora Franceschini; Lynda A Szczech; Susan L Koletar; Robert C Kalayjian
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

6.  The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy.

Authors:  Christina M Wyatt; Susan Morgello; Rebecca Katz-Malamed; Catherine Wei; Mary E Klotman; Paul E Klotman; Vivette D D'Agati
Journal:  Kidney Int       Date:  2008-12-03       Impact factor: 10.612

7.  HIV viremia and changes in kidney function.

Authors:  Chris T Longenecker; Rebecca Scherzer; Peter Bacchetti; Cora E Lewis; Carl Grunfeld; Michael G Shlipak
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

8.  CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.

Authors:  Jason V Baker; Grace Peng; Joshua Rapkin; Donald I Abrams; Michael J Silverberg; Rodger D MacArthur; Winston P Cavert; W Keith Henry; James D Neaton
Journal:  AIDS       Date:  2008-04-23       Impact factor: 4.177

9.  Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy.

Authors:  Miguel Goicoechea; Shanshan Liu; Brookie Best; Shelly Sun; Sonia Jain; Carol Kemper; Mallory Witt; Catherine Diamond; Richard Haubrich; Stan Louie
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

10.  HIV and the Kidney.

Authors:  Leslie A Bruggeman; Charles Bark; Robert C Kalayjian
Journal:  Curr Infect Dis Rep       Date:  2009-11       Impact factor: 3.725

View more
  5 in total

Review 1.  Risk of coronary heart disease in patients with HIV infection.

Authors:  Markella V Zanni; Judith Schouten; Steven K Grinspoon; Peter Reiss
Journal:  Nat Rev Cardiol       Date:  2014-10-21       Impact factor: 32.419

Review 2.  Renal dysfunction in the setting of HIV/AIDS.

Authors:  Jose M Miro; Federico Cofan; Joan C Trullas; Christian Manzardo; Carlos Cervera; Montserrat Tuset; Federico Oppenheimer; Mercedes Brunet; Asuncion Moreno; Josep M Campistol; Jose M Gatell
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

3.  Microalbuminuria in HIV disease.

Authors:  Colleen Hadigan; Elizabeth Edwards; Alice Rosenberg; Julia B Purdy; Estee Fleischman; Lilian Howard; JoAnn M Mican; Karmini Sampath; Akinbowale Oyalowo; Antoinette Johnson; Alexandra Adler; Catherine Rehm; Margo Smith; Leon Lai; Jeffrey B Kopp
Journal:  Am J Nephrol       Date:  2013-04-20       Impact factor: 3.754

4.  Prevalence of renal disease within an urban HIV-infected cohort in northern Italy.

Authors:  Leonardo Calza; Elisa Vanino; Eleonora Magistrelli; Caterina Salvadori; Alessandra Cascavilla; Vincenzo Colangeli; Maria Assunta Di Bari; Roberto Manfredi; Pierluigi Viale
Journal:  Clin Exp Nephrol       Date:  2013-05-28       Impact factor: 2.801

5.  Impaired Urine Dilution Capability in HIV Stable Patients.

Authors:  Waldo H Belloso; Mariana de Paz Sierra; Matilde Navarro; Marisa L Sanchez; Ariel G Perelsztein; Carlos G Musso
Journal:  Int J Nephrol       Date:  2014-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.